To ensure there is no shortage of essential drugs in India due to the lockdown in China’s Hubei’s province, the government is considering putting a stop to the exports of 12 essential drugs. China’s Hubei’s province is not only the epicenter of the outbreak of the Coronavirus, but also a major supplier of 80-85% of raw material or active pharmaceutical ingredient used to make medicines.
This moves comes in the wake of the suggestion offered by an eight-member expert committee constituted by the government (to gauge availability of medicines in the country) to impose such a ban. The 12 drugs identified for the purpose include antibiotics like chloramphenicol, neomycin, metronidazole, azythromicin, clindamycin; vitamin B1, B2 and B6; as well as hormones like progesterone used during pregnancy and in menstrual related problems. It has also advised the government to invoke provisions of the Essential Commodities Act and launch a strong vigil against hoarders and any kind of artificial dearth of medicines.
“We have finalised the report and will submit it to the government by Tuesday,” a panelist stated.
You must be logged in to post a comment.
Stay ahead in the dynamic world of trade and commerce with India Business & Trade's weekly newsletter.